Compensated cirrhosis

美 [ˈkɑːmpenseɪtɪd səˈroʊsɪs]英 [ˈkɒmpenseɪtɪd səˈrəʊsɪs]
  • 网络代偿性肝硬化;代偿期肝硬化;肝硬化代偿
Compensated cirrhosisCompensated cirrhosis
  1. Evaluation of ultrasonographic scoring system in diagnosis of compensated cirrhosis in patients with chronic liver disease

    超声波评分系统对代偿性肝硬化的诊断价值

  2. Methods The stable isotope tracer technique was used to determinate the protein synthetic and catabolic rates in 18 healthy objects , 15 patients with compensated cirrhosis and 17 patients with decompensated cirrhosis .

    方法用稳定同位素示踪技术测定18例对照组和15例代偿期肝硬化及17例失代偿期肝硬化患者的蛋白质合成与分解速率。

  3. Methods : Normal cases compensated cirrhosis and decompensated cirrhosis each 100 cases respectively were selected at random .

    方法:随机选择正常肝脏、代偿期和失代偿期肝硬化各100例。

  4. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation ( RFTA ): A prospective study

    射频消融(RFTA)技术治疗处于肝硬化代偿期的肝细胞癌的前瞻性研究

  5. Correlation between Compensated Cirrhosis and the Peak Enhancement and Time to Peak Enhancement of Main Trunk of Portal Vein on Spiral CT

    门静脉螺旋CT增强峰值、峰值时间与肝硬化代偿期相关性研究

  6. The results revealed that the activity of phenylalanine hydroxylase was impaired in cirrhotic patients and the impairment was more severe in decompensated than in compensated cirrhosis .

    ~2H-Tyr/~2H-Phe丰度比时相曲线下的面积。实验结果表明:代偿性肝硬化病人的苯丙氨酸羟化酶活力低于正常人,失代偿肝硬化病人的该酶活力又低于代偿性肝硬病人。

  7. RBC aggregation index , plasma viscosity ( PV ) and the low-shear BV were significantly higher in compensated cirrhosis group than those in the control group ( P0.05 ) .

    代偿期组全血低切粘度、血浆粘度、红细胞聚集指数明显升高(P0.05);

  8. Material and Method : Dynamic contrast-enhanced single-location sequences CT scans of the liver were obtained in 68 individuals who included 29 control subjects , 22 patients with compensated cirrhosis and 17 patients with decompensated cirrhosis proven by clinical .

    材料与方法取68例肝脏CT灌注扫描,其中29例正常对照者,22例代偿期肝硬化患者,17例失代偿期肝硬化患者。

  9. That is , normal control < Chronic hepatitis < compensated cirrhosis < decompensated cirrhosis The sensitivity of portal shunt index , B-mode ultrasound and liver function tests were 92.3 % , 77.4 % and 70 . 9 % , respectively . The specificity .

    研究表明,核素门脉分流指数随着慢性肝病的肝纤维化进程不断升高,正常人<慢性肝炎<代偿期肝硬化<失代偿期肝硬化。本法敏感性为92.3%,B超为77.4%,肝功能总体为70.9%;

  10. The total ratio of direct to indirect cost was 1.4:1 . Among which , compensated cirrhosis was the highest ( 4.5:1 ), hepatocellular was the lowest ( 0.3:1 ) . The direct medical costs were higher than that of the direct nonmedical ( the ratio was 16.1:1 ) .

    直接和间接费用的比例为1.4:1,其中,代偿期肝硬化最高4.5:1,原发性肝癌最低0.3:1;直接医疗费用高于直接非医疗费用(16.1:1)。

  11. Objective To explore the significance and their relationship of plasma NO , IL-8 and TNF-a in patients with compensated cirrhosis and decompensated cirrhosis after hepatitis B. Methods we detected plasma NO , IL-8 and TNF-a in 52 patients with liver cirrhosis after hepatitis B by colorimetric and ELISA method .

    目的探讨乙型肝炎后肝硬化代偿期与失代偿期患者血清NO、IL-8及TNF-α的意义及其相互关系。

  12. Portal Shunt Index in the Diagnosis of Compensated Liver Cirrhosis

    门脉分流指数对代偿期肝硬化的诊断应用

  13. Observation on therapeutic effect of acupuncture combined with Chinese herbal decoction on compensated liver cirrhosis

    针刺配合药物治疗代偿期肝硬化疗效观察

  14. Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B

    代偿性肝硬化无创性诊断指标的筛选及评价

  15. Aim To perform a systematic review of the literature to establish the outcome of compensated HCV cirrhosis .

    目的:对相关文献进行一项系统综述,来确定HCV相关性代偿期肝硬化的结局。

  16. CONCLUSION : SM injection can improve the coagulation function and lower the rate of bleeding complication in patients with de - compensated liver cirrhosis .

    结论:丹参注射液能够改善失代偿期肝硬化患者的凝血功能,降低临床出血率,提示丹参注射液治疗失代偿期肝硬化是安全有效的。

  17. Conclusions These rates highlight the need for continued vigilance for the occurrence of HCC , while confirming the relatively slow progress of compensated HCV cirrhosis .

    结论:这些数据强调,当确定存在HCV相关的代偿期肝硬化缓慢进展时,依然需要警惕HCC的发生。

  18. Apolipoproteins ( ADO ) A-I and B_ ( 100 ) levcls were measured by rocket immunoelectrophoresis assay in 70 patients with AH , CAH , LC ( both compensated liver cirrhosis and decompensated liver cirrhosis ), SH and 23 healthy controls .

    采用火箭免疫电泳法检测急、慢性肝炎、肝硬化、重症肝炎共70例和健康献血员23例血清载脂蛋白(Apo)A-Ⅰ、B(100)含量。

  19. Predicting compensated hepatitis B cirrhosis with index combination of B-mode ultrasonography

    B型超声指标组合预测代偿性乙肝肝硬化

  20. The Role of Gut Barrier in the Course of Compensated to Decompensated Cirrhosis in Rats

    肠黏膜屏障在肝硬化代偿期向失代偿期转化中作用的实验研究

  21. RESULTS The incidence of acquired pneumonia accounted for 43 % and 31 % , respectively in compensated and decompensated cirrhosis . The main reasons were unreasonable use of antibiotics and immune regulators .

    结果代偿性肝硬化患者的获得性肺炎发生率为42%,失代偿性肝硬化者为31%,其主要诱发因素为应用抗生素及免疫调节剂不合理;

  22. Methods The components of the economic burden of disease included direct medical costs and non medical costs as well as indirect economic loss per patient year in patients with chronic hepatitis B virus infections , including chronic hepatitis B , compensated and decompensated cirrhosis , and hepatocellular carcinoma .

    方法根据慢性乙型肝炎、代偿性肝硬化、失代偿性肝硬化和肝癌病人的年直接医疗费用、直接非医疗费用以及间接费用计算其经济负担。

  23. The results showed that Liver - Blood - Stasis was a common pathological basis for cirrhosis in any developing stage ; during compensated stage of cirrhosis , average Pugh Grading was 3.3 , depression of Liver - energy was dominant and Spleen - insufficiency was inferior in this stage ;

    发现肝血瘀阻是肝硬化不同发展阶段的共同病理基础,在肝硬化代偿期,Pugh分级平均3.3分,以肝气郁结为主,以脾虚为辅;